Antagonist effects on human P2X7 receptor-mediated cellular accumulation of YO-PRO-1

British Journal of Pharmacology

Volumn 130, Issue 3, 2000, Pages 513-520

  Michel, A D ^a   Kaur, R ^a   Chessell, I P ^a   Humphrey, P P A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

KN62; Oxidized ATP; PPADS; YO PRO 1

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALMIDAZOLIUM; DYE; MONOCLONAL ANTIBODY; N [1 [4 (5 ISOQUINOLINESULFONYL) ALPHA METHYLBENZYL] 2 (4 PHENYL 1 PIPERAZINYL)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR SUBTYPE; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0034077280     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703368     Document Type: Article

References (20)

1. BLANCHARD, D.K., HOFFMAN, S.L. & DJEU, J.Y. (1995). Inhibition of extracellular ATP-mediated lysis of human macrophages by calmodulin antagonists. J. Cell Biochem., 57, 452-464.
2. 7 receptor function with a monoclonal antibody. Blood, 92, 3521-3528.
3. BUELL, G., LEWIS, C., COLLO, G., NORTH, R.A. & SURPRENANT, A. (1996). An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J., 15, 55-62.
4. 7 receptor. Br. J. Pharmacol., 124, 1314-1320.
5. 7 large pore formation. Br. J. Pharmacol., 126, 19P.
6. GARGETT, C.E. & WILEY, J.S. (1997). The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br. J. Pharmacol., 120, 1483-1490.
7. 2+ by receptors. Nature, 306, 64-66.
8. HICKMAN, S.E., EL KHOURY, J., GREENBERG, S., SCHIEREN, I. & SILVERSTEIN, S.C. (1994). P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood, 84, 2452-2456.
9. 7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol. Pharmacol., 54, 22-32.
10. KENNAKIN, T. (1993). Allotopic, Noncompetitive and Irreversible Antagonism. Pharmacologic Analysis of Drug-Receptor Interaction. Raven press: pp 323-343.
11. KHAKH, B.S., BAO, X.R., LABARCA, C. & LESTER, H.A. (1999). Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nature Neurosci., 2, 322-330.
12. 7 receptor-mediated YO-PRO1 influx by PPADS and KN62. Br. J. Pharmacol., 123, 103P.
13. 7 receptor function. Naunyn-Schmiedebergs Arch. Pharmacol., 359, 102-109.
14. MURGIA, M., HANAU, S., PIZZO, P., RIPPA, M. & DI VIRGILIO, F. (1993). Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem., 268, 8199-8203.
15. RASSENDREN, F., BUELL, G.N., VIRGINIO, C., COLLO, G., NORTH, R.A. & SURPRENANT, A. (1997). The permeabilizing ATP receptor, P2X7. cloning and expression of a human cDNA. J. Biol. Chem., 272, 5482-5486.
16. 4 permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem., 262, 8884-8888.
17. SURPRENANT, A., RASSENDREN, F., KAWASHIMA, E., NORTH, R.A & BUELL, G. (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X(7)). Science., 272, 735-738.
18. 4- receptor that mediates permeabilisation of rat mast cells. Eur. J. Pharmacol., 147, 13-21.
19. 7 receptor. Neuropharmacology. 36, 1285-1294.
20. VIRGINIO, C., MACKENZIE, A., RASSENDREN, F.A., NORTH, R.A. & SURPRENANT, A. (1999). Pore dilation of neuronal P2X receptor channels. Nature Neurosci., 2, 315-321.